Abstract
Left subclavian artery revascularization (LSAR) during thoracic endovascular aneurysm repair (TEVAR) is an area of constant debate. Zone 2 aortic pathologies necessitate LSA coverage. Recent studies demonstrated no added immediate benefit for LSAR in chronic type B dissection. We sought to evaluate short and long-term outcomes after LSAR in patients with aneurysmal and nonaneurysmal aortic diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
